AptuitがCMO4部門でLife Science Leader誌のCMO Leadership Awardsを受賞

Aptuit Holdings, LLC

2017/3/13 16:21

AptuitがCMO4部門でLife Science Leader誌のCMO Leadership Awardsを受賞

AsiaNet 67760 (0365)

【グリニッチ(米コネティカット州)2017年3月13日PR Newswire=共同通信JBN】Aptuit, LLCは13日、同社がLife Science Leader誌からManufacturer Organization (CMO) Leadership Awardsの4部門の受賞者に選ばれたと発表した。Aptuitは、過去18カ月内にプロジェクトを外注した医薬品・バイオ医薬品会社の調査から選出された。顧客は、期待以上もしくはトップ貢献者のいずれかに該当するCMO受賞者を判定する。

Logo: http://photos.prnewswire.com/prnh/20150709/234432LOGO

Aptuitは4つの部門の受賞者として指名された。大手製薬会社で働く調査対象者の中から、Aptuitは専門知識、質、適合性でCMO Leadership Awardsを受賞した。Aptuitはさらにまた、回答が大手および小規模製薬会社双方の調査参加者を合わせた専門知識の受賞部門で期待以上であったことを認められた。


Life Science Leader誌およびOutsourcedPharma.comのルイズ・ガルジューロ編集長は「CMO Leadership Awardsは毎年、個々の医薬品開発・製造組織がそのバイオテクノロジー・製薬会社の顧客とパートナーのニーズに貢献したことで得る成功を評価している。受賞者は、能力、適合性、専門知識、質、信頼性そして開発の6つの重要部門で、CMOが役立つスポンサーの経営者やマネジャーから評価される。これらすべての部門の賞はどれも、より大きな医薬品発見、開発、製造、マーケティング業界内のCMOの優秀さと評価を増大することになる」と語った。

Industry Standard Research(ISR)のアンドルー・シャファー社長は「Industry Standard Researchは、Life Science Leader誌のCMO Awardsに対する研究調査を実施している。契約製造の基準設定研究に参画するため必要な、ISRの極めて厳格な先行過程と質の高い資格認定は、実際の顧客が過去18カ月にわたり契約供給業者との接触で実際に得た意見を提供することを意味する。これによってISR調査研究のユーザーは、業界仲間の経験に基づいてビジネス上の決定をする際に、確信を持つって行うことを可能にする」と述べた。



Aptuit Holdings, LLCは、世界的な有力プライベートエクイティ投資家であるWelsh、Carson、Anderson & Stoweと提携している。

さらに詳しい情報は、http://www.aptuit.com を参照。

ソース:Aptuit Holdings, LLC

Aptuit Selected as a Winner of Life Science Leader Global Award for Contract Drug Manufacturer in Multiple Categories


GREENWICH, Connecticut, Mar. 13, 2017 /PRNewswire=KYODO JBN/ --

     Aptuit, LLC today announced that the company has been selected as a winner

of four Contract Manufacturer Organization (CMO) Leadership Awards by Life

Science Leader magazine. Aptuit was selected from a survey of pharma and

biopharma companies who had outsourced projects within the past 18 months.

Customers judge CMO winners as either exceeding expectations or as top


    (Logo: http://photos.prnewswire.com/prnh/20150709/234432LOGO )

    Aptuit was named as a winner in four categories. From the survey

participants who worked for Big Pharma, Aptuit was awarded CMO Leadership

Awards in Expertise, Quality, and Compatibility. Aptuit was also recognized for

exceeding expectations in the award category of Expertise when responses were

combined from survey participants from both Big and Small Pharma.

    Henning Steinhagen, Executive VP, Drug Discovery & Development, Aptuit,

commented, "These awards demonstrate that our customers recognize and value the

depth of experience of our scientists and the high quality of our operations.

Aptuit differentiates by combining large pharma expertise and capabilities with

the flexible cost effective approach of the only Partner Research Organization.

We are truly honored to receive these awards as they come directly from the

feedback of real customers."

    "Each year, the CMO Leadership Awards recognize the success that individual

drug development and manufacturing organizations have in serving the needs of

their biotechnology and pharmaceutical customers and partners," says Louis

Garguilo, Executive Editor, Life Science Leader magazine and

OutsourcedPharma.com. "Recipients are evaluated by the executives and managers

at the sponsors the CMOs have worked, in the six critical categories of

capabilities, compatibility, expertise, quality, reliability and development.

An award in any of these categories adds to the distinction and reputation of

CMOs within the greater drug discovery, development, manufacturing and

marketing industries."

    "Industry Standard Research is honored to conduct the research for Life

Science Leader's CMO Awards. ISR's stringent screening processes and the high

caliber of qualification required to participate in our contract manufacturing

benchmarking research means that real customers provide experiential feedback

on their involvement with contract suppliers over the past 18months. This

enables users of ISR's research to make confident business decisions based on

the experiences of their industry peers," said Andrew Schafer, President of

Industry Standard Research.

    About Aptuit

    Aptuit provides the most complete set of integrated early discovery to

mid-phase drug development services in the pharmaceutical industry including

Drug Design & Discovery, API Development and Manufacture, Solid State

Chemistry, CMC, Preclinical and IND enabling GLP/GMP programs. Fully integrated

drug discovery & development services are available from our facilities in the

UK, Italy, and Switzerland.

    Aptuit Holdings, LLC is partnered with Welsh, Carson, and Anderson & Stowe,

one of the world's leading private equity investors.

    For more information, please visit: http://www.aptuit.com.

    SOURCE: Aptuit Holdings, LLC